Enova (ENVA) insider trade: 11,436 options exercised, sales near $121
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Enova International (ENVA) disclosed insider transactions by its Chief Financial Officer and director. On 10/29/2025, the reporting person exercised stock options for 11,436 shares at an exercise price of $20.73 per share. The same day, they sold 11,436 shares at a weighted average price of $120.76, with trades executed between $120.52 and $121.00. A separate sale of 3,438 shares occurred at $120.50.
After these transactions, the reporting person directly owned 127,719 shares of Enova common stock. The filing notes the options were part of a non-qualified stock option with a limited stock appreciation right granted in tandem and previously vested in thirds on February 11 of 2021, 2022, and 2023.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 14,874 shares ($1,795,290)
Net Sell
4 txns
Insider
Cunningham Steven E
Role
Chief Financial Officer
Sold
14,874 shs ($1.80M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR | 11,436 | $0.00 | -- |
| Exercise | Common stock, par value $0.00001 per share | 11,436 | $20.73 | $237K |
| Sale | Common stock, par value $0.00001 per share | 11,436 | $120.76 | $1.38M |
| Sale | Common stock, par value $0.00001 per share | 3,438 | $120.50 | $414K |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) with limited SAR — 11,436 shares (Direct);
Common stock, par value $0.00001 per share — 142,593 shares (Direct)
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $120.52 to $121.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022 and February 11, 2023.
FAQ
What insider transactions did ENVA report?
The CFO and director exercised options for 11,436 shares at $20.73 and sold 11,436 shares at a weighted average of $120.76, plus a separate sale of 3,438 shares at $120.50.
What was the exercise price of the ENVA stock options?
The options were exercised at $20.73 per share.
When did the ENVA insider transactions occur?
The transactions occurred on 10/29/2025.
What roles does the reporting person hold at ENVA?
The reporting person is a Director and Chief Financial Officer.